A detailed history of Advisor Os, LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Advisor Os, LLC holds 3,899 shares of GILD stock, worth $343,423. This represents 0.03% of its overall portfolio holdings.

Number of Shares
3,899
Previous 3,971 1.81%
Holding current value
$343,423
Previous $290,000 7.93%
% of portfolio
0.03%
Previous 0.03%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 05, 2024

SELL
$63.15 - $72.88 $4,546 - $5,247
-72 Reduced 1.81%
3,899 $267,000
Q1 2024

May 08, 2024

BUY
$71.58 - $87.29 $17,322 - $21,124
242 Added 6.49%
3,971 $290,000
Q4 2023

Feb 07, 2024

BUY
$73.27 - $83.09 $12,748 - $14,457
174 Added 4.89%
3,729 $302,000
Q3 2023

Nov 02, 2023

SELL
$73.94 - $80.67 $625,976 - $682,952
-8,466 Reduced 70.43%
3,555 $266,000
Q2 2023

Aug 08, 2023

SELL
$76.01 - $86.7 $558,901 - $637,505
-7,353 Reduced 37.95%
12,021 $926,000
Q1 2023

Apr 24, 2023

SELL
$77.31 - $88.08 $46,695 - $53,200
-604 Reduced 3.02%
19,374 $1.61 Million
Q4 2022

Jan 31, 2023

BUY
$62.32 - $89.47 $265,732 - $381,500
4,264 Added 27.14%
19,978 $1.72 Million
Q3 2022

Nov 03, 2022

BUY
$59.54 - $68.01 $66,387 - $75,831
1,115 Added 7.64%
15,714 $970,000
Q2 2022

Aug 02, 2022

BUY
$57.72 - $65.01 $306,550 - $345,268
5,311 Added 57.18%
14,599 $902,000
Q1 2022

May 11, 2022

BUY
$57.92 - $72.58 $158,063 - $198,070
2,729 Added 41.61%
9,288 $552,000
Q4 2021

Feb 04, 2022

BUY
$64.88 - $73.64 $425,547 - $483,004
6,559 New
6,559 $477,000

Others Institutions Holding GILD

About GILEAD SCIENCES, INC.


  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $110B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Advisor Os, LLC Portfolio

Follow Advisor Os, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisor Os, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Advisor Os, LLC with notifications on news.